PALO ALTO, Calif., Jan. 19, 2021 /PRNewswire/ -- Varian (NYSE: VAR)
has been recognized again as the leader in the annual IMV
ServiceTrak™ Radiation Oncology Systems report, ranking first in
all nine of the tracked categories. Additionally, Varian's Net
Promotor Score (NPS) improved from 78 in 2019 to 85 in 2020—the
highest NPS among industry competitors. NPS represents the
likelihood a customer would recommend a manufacturer to a
colleague.
"This annual survey is very important to us because we are
laser-focused on providing value to our customers, and this gives
us direct feedback about how we're doing. It is a sign we are
meeting and exceeding our customers' needs, which is what we strive
to do—because we never forget that our customers are helping cancer
patients—the ultimate beneficiaries when we're successful," said
Kevin O'Reilly, president of
Varian's Oncology Systems business.
"In addition to these rankings, we are pleased at the
accelerated trajectory of improvement in NPS score, year-over-year,
during an especially difficult year, when our service teams really
had to go the extra mile to be able to provide service safely
during a pandemic. A score of 85 puts us in the top quartile of NPS
scores—across all industries," O'Reilly added.
For the fourth year in a row, Varian achieved the top ratings
for Best Customer Satisfaction, Best System Performance, and Best
Service. In the current, 2020 report, the nine categories for
which Varian ranked first
included:
- System Uptime Meets Expectations
- Technology Leadership
- Reliability of Hardware
- Competence of Service Engineer
- Overall OEM Applications Training Program
- System Software Ease of Use
- Ease of Integration – Treatment Planning
- Overall Service Performance
- Service Follow-up
The IMV ServiceTrak Radiation Oncology Systems report is a
survey of U.S. hospital oncology professionals who perform
therapeutic radiation oncology treatments using external beam
radiation therapy systems. The survey results from interviews with
345 unique radiation therapy sites representing 533 systems.
Respondents participated in online data collection between
April 28, 2020 – August 31, 2020 and during phone interviews from
July 14, 2020 – September 1, 2020.
About Varian
At Varian, we envision a world without
fear of cancer. For more than 70 years, we have developed, built
and delivered innovative cancer care technologies and solutions for
our clinical partners around the globe to help them treat millions
of patients each year. With an Intelligent Cancer Care approach, we
are harnessing advanced technologies like artificial intelligence,
machine learning and data analytics to enhance cancer treatment and
expand access to care. Our 10,000 employees across 70 locations
keep the patient and our clinical partners at the center of our
thinking as we power new victories in cancer care. Because, for
cancer patients everywhere, their fight is our fight. For more
information, visit http://www.varian.com and follow
@VarianMedSys on Twitter.
About IMV
IMV Medical Information Division, part of
Science and Medicine Group, specializes in researching the medical
imaging and other advanced healthcare technology markets.
IMV's ServiceTrak™ annual series of reports benchmark and monitor
customer satisfaction with equipment manufacturers, system
performance by product type, and service providers. For more
information, please visit www.imvinfo.com.
Investor Relations Contact
Global
Anshul Maheshwari
VP, Treasurer and Investor Relations
1 (650) 424-6081
investors@varian.com
Press Contacts
Aimee Corso
Health + Commerce on behalf of Varian
+1 (310) 780-2661
aimee@healthandcommerce.com
View original
content:http://www.prnewswire.com/news-releases/varian-ranked-highest-in-survey-of-us-radiation-oncology-professionals-301209698.html
SOURCE Varian